|Clinical Trial Title||A Phase III Clinical Trial Evaluating DE-escalation of Breast RAdiation (DEBRA) for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer|
|Trial Status||Open to Enrollment|
|Trial Type||Cancer - Adult Oncology|
|Specific Condition||Breast Cancer|
|Description||This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.|
Patients with any of the following conditions are NOT eligible for this study.
Please contact Legacy Oncology Research for additional study inclusion/exclusion information.
|IRB Number||Central IRB|
|Notes||De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) - Full Text View - ClinicalTrials.gov|
|Principal Investigator||Andrew Kee, MD|
|Contact Name||Oncology Clinical Research|